clinical application
RABIOPRED - Clinical validation of BIOmarker assay
clinical centers
clinical decision-making
clinical practice
RABIOPRED assay
treatment response
clinical performance evaluation
RABIOPRED project
Millions of RA patients
multibillion market
prototype biomarker assay
TcLand Expression SA
initial market introduction
TcLand focusses
TNF-Î± inhibitors
CE registered IVD biomarker assay
subsequent market uptake of novel biomarkers assays
final development steps
final steps
expensive biological RA therapies
Rheumatoid Arthritis
current project
analytical validation
novel gene expression signature
year project
agents
main second-line treatment strategies
innovative set of biomarkers
health outcomes
validation of noninvasive multi-gene molecular diagnostic blood tests
health care system
personalized medicine
companion diagnostics
French SME
Europe
pharmaceutical companies
immune mediated disorders
sustainability
cost reduction
aim
predictive model
international network
commercialization
implementation
end
Proof
concept
Clinicians